Clinical Trial Update: Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1b trial assessing weekly carfilzomib with lenalidomide and dexamethasone in multiple myeloma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2020-11-06